Home » Pharmaceutical companies » Top 10 Pharmaceutical Companies in India 2024

Top 10 Pharmaceutical Companies in India 2024

There are many pharmaceutical manufacturing companies in India, but only a few are leading in the manufacturing and marketing of pharmaceutical products. We have prepared a list of India’s top 10 pharmaceutical manufacturing companies in 2024 according to recent data obtained from different sources. The list is based on their current growth with their regulatory approval and market authorization with their manufacturing Location.

Top Pharmaceutical Companies list

Lost of Top 10 pharmaceuticals in India 2023-24

#1. Sun Pharmaceutical Industries Ltd.

sun Pharma

Market Cap
2.65 trillion INR

Revenue
₹ 43279 Cr.

Net Profit
₹ 8513 Cr.

Sun Pharmaceutical is the largest Indian multinational pharmaceutical company with More than 40 manufacturing sites. Dilip Sanghavi founded Sun pharma.

The company headquarters is in India known as the financial capital (Mumbai), Maharashtra. Active pharmaceutical ingredients (APIs) and formulations are known to be Sun Pharma’sPharma’s specialized areas. It targets a broad spectrum of chronic and acute treatments.

It has therapeutic segments of over 3000 prime quality molecules like; psychopathology, anti-infectives, neurology, cardiology, orthopedical, diabetology, gastric drugs, medical specialty, nephrology, urology, skin-related, gynecology, respiratory, oncology, dental, and Nutritionals. In June 2019, Sun Pharma was India’s largest pharmaceutical company and stayed in position number 1 among the top 10 pharmaceutical companies with a market capitalization valued at Rs. 1,68,768.88 cr.

  • As per current Data Sun Pharma has More than 2000 research scientists working in different R&D Centers.
  • Its R&D Center is approved by various regulatory bodies, including the USFDA and European authorities

Approved by following regulatory

Sun Pharma has different regulatory approvals:

  • US FDA
  • EMA, Europe
  • MHRA, UK MCC,
  • South Africa
  • TGA, Australia
  • ANVISA, Brazil
  • WHO, Geneva

Sun Pharma Manufacturing plant Location In India:

  • Halol, Gujarat
  • Baska, Gujarat
  • Panoli, Gujarat
  • Ankleshwar, Gujarat
  • Dadra, Dadra & Nagar Haveli
  • Silvassa, Dadra & Nagar Haveli
  • Jammu, JK
  • Sambha, JK
  • Baddi, Himachal Pradesh
  • Batamandi, Himachal Pradesh
  • Goa
  • Guwahati, Assam
  • Toansa, Punjab
  • Malanpur, Madhya Pradesh
  • Ahmednagar, MAHARASHTRA
  • Dewas, Madhya Pradesh
  • Paonta Sahib, Himachal Pradesh
  • Mohali, Punjab
  • Sikkim

#2. Aurobindo Pharma

Aurobindo Pharma

Market Cap
483.90 bill. INR

Revenue
₹ 24617 Cr.

Net Profit
₹ 1928 Cr.

Aurobindo Pharmaceutical Company began the initial Unit at Pondicherry in 1986 by Mr. P. V. Ramprasad Reddy, and Mr. K. Nityananda Reddy, Beginning with the semi-synthetic antibiotic drug penicillin, now it has the largest R&D Facilities.

Regulatory Exposure:

  • US FDA
  • MHRA, UK
  • And various WHO bodies.

Aurobindo Plant is Located In India in the Following Location:

  • Gurugram, Haryana
  • Unit XIV & XV Donkada, Andhra Pradesh
  • Unit III, Bachupally, Telangana
  • Aurobindo Pharma P Ltd
  • Chennai, Tamil Nadu
  • Aurobindo Pharma LTD
  • Mumbai, Maharashtra
  • Aurobindo Unit 10
  • Palapalam, Andhra Pradesh
  • Hyderabad, Telangana Aurobindo Pharma Unit 17

Related post: Pharmaceuticals in Hyderabad / Telangana

#3. Dr. Reddy’s Labs

Dr Reddy

Market Cap
962.30 bill. INR

Revenue
₹ 24588 Cr.

Net Profit
₹ 4507 Cr.

Company Founder Kallam Anji Reddy was born in Tadepalli, Andhra Pradesh. His father was a farmer. He Saw His Father build herbal drugs and distribute them at no cost. He started to think about starting a pharmaceutical when he was pursuing a BSc Tech degree at the University Department of Chemical Technology, Mumbai. Kallam Anji Reddy Joined IDPL Pharma worked for six years and left IDPL in 1973 for the next 10 Years, Kallam Anji Reddy was a member of two manufacturing Units. In 1984 He Decided to establish Dr. Reddy’sReddy’s Laboratories.

Dr. Reddy Regulatory exposure:

  • US FDA
  • UK, MHRA
  • TGA, Australia
  • WHO, and MCC South Africa

Dr. Reddy’sReddy’s Plant is Located In India in the Following Location:

  • Hyderabad plants 1,2 and 3 in Telangana
  • Baddi plant 1,khol, Nalagarh, Himachal Pradesh
  • Baddi plant 2, Maunja Thana, Nalagarh Himachal Pradesh
  • Vizag SEZ plant 1, Duvvada, plot no.p1-p9, Visakhapatnam
  • Vizag SEZ plant 2, Duvvada, plot no. q1-q5, Visakhapatnam
  • Srikakulam SEZ plant Unit two, Ranastalam Mandal, Andhra Pradesh.

Related: List of 100+ pharmaceutical companies in Baddi

#4. Cipla

Cipla pharma

Market Cap
977.28 bill. INR

Revenue
₹ 24588 Cr.

Net Profit
₹ 4507 Cr.

Cipla Co-founder is Khwaja Abdul Hamied. Cipla is a leading company with high-quality products for every branded and generic Medicine; over the last eight decades, we have strengthened our leadership in India’s pharmaceutical industry.

Regulatory exposure:

  • US FDA
  • MHRA, UKTGA, Australia
  • Federal Ministry of Health-Germany
  • MCC, South Africa
  • The Department of Health, Canada
  • INVIMA, Columbia
  • ANVISA, Brazil
  • WHO and Health Ministry of various Countries

Cipla Plant is Located In India in the Following Location:

  • BLOCK, TAZA East Sikkim, Sikkim
  • Verna. GOA
  • Virgo Nagar, Bangalore
  • Pune, MIDC, Maharashtra
  • Raigad, MIDC, Maharashtra
  • Indore, Dhar Distt., Madhya Pradesh
  • Kumrek, East Sikkim
  • Malpur, Distt., Solan, Himachal Pradesh

#5. Zydus Lifescience

Zydus Life science

Market Cap
636.17 bill. INR

Revenue
₹ 16878 Cr.

Net Profit
₹ 2097 Cr.

Zydus Cadila, Founded by Raman Bhai Patel, Ranks 7th in Indian pharmaceuticals among the top 10 pharmaceutical companies by 2020, Its presence worldwide in more than 25 countries and an additional than thirty producing sites across India, the US, and Brazil.

Regulatory Exposure:

  • US FDA
  • MHRA, UK

Zydus Currently operates a plant in India:

  • Baddi, Himachal Pradesh
  • Sikkim
  • Gujarat
  • Goa
  • Maharashtra
  • Zydus Animal Health, Haridwar, Uttarakhand.

#6. Lupin

lupin pharma

Market Cap
490.92 bill. INR

Revenue
₹ 16270 Cr.

Net Profit
₹ 430 Cr.

Lupin Pharmaceuticals’ headquarters is located in Mumbai, the name of Lupin’s Founder is Dr. Desh Bandhu Gupta, Founder and Former Chairman of LUPIN LTD. Lupin’sLupin’s world-class manufacturing plant is located in India, Japan, the USA, Mexico, and Brazil.

Lupin Regulatory exposure;

  • US FDA
  • UK, and MHRA
  • TGA, Australia, WHO, and MCC South Africa.

Lupin Plant Located In India in the Following Location:

  • Jammu, JK
  • Indore, Madhya Pradesh
  • Ankleshwar & Dabasa, Gujarat
  • Tarapur, Aurangabad, and Nagpur, Maharashtra
  • Goa
  • Visakhapatnam, Andhra Pradesh
  • Sikkim and research center at Pune and Aurangabad.

#7. Glenmark Pharma

Glenmark Pharma

Market Cap
208.58 bill. INR

Revenue
₹ 12725 Cr.

Net Profit
₹ 377 Cr.

Glenmark’s Founder is Gracias Saldanha. He has two sons, Glenn Saldanha, currently present as chief executive officer of Glenmark. Mark Saldanha is a chief executive officer of Markson’sMarkson’s pharmaceutical company, With seventeen producing facilities and five R&D Centres dedicated to the goal of enriching life.

Regulatory Exposure:

  • US FDA
  • MHRA
  • TGA
  • ANVISA and more

Plant Located In India in the Following Location:

  • Baddi, Himachal Pradesh
  • Goa
  • Nalagarh
  • Sikkim
  • Nasik
  • Indore
  • Aurangabad.

#8. Alkem Laboratories

Alkem Laboratories

Market Cap
440.01 bill. INR

Revenue
₹ 11599 Cr.

Net Profit
₹ 1007 Cr.

Alkеm Laboratoriеs Ltd is an Indian pharmacеutical company that focuses on dеvеloping, manufacturing, and sеlling pharmacеutical and nutracеutical products. Thе company crеatеs brandеd gеnеrics, gеnеric mеdications, activе pharmacеutical ingrеdiеnts (APIs), and nutracеuticals across various mеdical arеas, including anti-infеctivе trеatmеnts, pain rеliеf, vitamins, minеrals, nutriеnts, hеart and diabеtеs carе, gynеcology, nеurology, dеrmatology, anti-diabеtic solutions, anti-ostеoporosis trеatmеnts, cardiovascular mеdications, and musclе rеlaxants. Thеsе products arе markеtеd both in India and internationally markеts. The company’s opеrations primarily rеvolvе around its pharmacеutical business division.

Founder: Samprada Singh

Regulatory Approval: USFDA, UK MHRA, and TGA

#9. Biocon

Biocon Pharma

Market Cap
305.12 bill. INR

Revenue
₹ 3929 Cr.

Net Profit
₹ 643 Cr.

Thе Biocon Group is dеdicatеd to achiеving health fairnеss by providing high-quality, affordablе trеatmеnts that dеcrеasе еxpеnsеs, еnhancе accеssibility, and bеttеr trеatmеnt for community. Starting from modеst origins, it has dеvеlopеd into a fully intеgratеd, tеchnologically еmpowеrеd, forward-looking global biopharmacеutical lеadеr.

Ovеr thе yеars, it has consistеntly transformеd itsеlf to bеcomе a divеrsifiеd, pionееring biopharmacеutical brand. Shifting from being primarily an еxport-focusеd еnzymеs company, it еxpandеd its rеach to includе rеsеarch sеrvicеs, biosimilars, and gеnеric drugs.

In today’s world, Biocon is changing thе livеs of patients in more than 120 countries, by uncovеring novеl and еconomical mеthods to managе chronic illnеssеs likе diabеtеs, cancеr, and autoimmunе disordеrs, among othеrs. From thе еarly stagеs of drug dеvеlopmеnt to final production, from discovеring nеw drugs to dеlivеring thеm, Biocon is incrеasing thе accеssibility of distinctivе, high-quality, and affordablе hеalthcarе products.

Thе Biocon Group dеlivеrs top-notch Activе Pharmacеutical Ingrеdiеnts (APIs) and finalizеd formulations through its Gеnеrics division. Thе APIs portfolio consists of a wеll-balancеd sеlеction of 50+ products across arеas likе cardiovascular hеalth, anti-diabеtic mеdications, immunosupprеssants, high potеncy APIs for oncology, as wеll as a sеlеction of spеcialty and nichе molеculеs. Thеsе APIs arе suppliеd to more than 750 pharmacеutical companies across 75+ countries, including thе Unitеd Statеs and Europе. Additionally, its array of gеnеric formulations еncompassеs cardiology, oncology, immunology, and autoimmunе trеatmеnts. This portfolio provides various forms such as oral solid dosagеs, injеctablеs (vials, prе-fillеd syringеs, auto-injеctors), and other formulations.

#10. Torrent Pharma

Torrent Pharma

Market Cap
651.85 bill. INR

Revenue
₹ 9464 Cr.

Net Profit
₹ 1245 Cr.

Torrent Pharma, Founded by Sudhir Mehta and Samir Mehta, operates in more than 50 countries, and over a thousand products registered Globally, with more than 8800 employees.

Regulatory Exposure:

  • US FDA
  • MHRA, UK
  • ANVISA, Brazil

Plant Located In India in the Following Location:

  • Dahej, Gujarat
  • Pitampura, Madhya Pradesh
  • Indrad, Mehsana, Gujarat
  • Baddi, Himachal Pradesh
  • Three manufacturing plants at Rangpo, Sikkim
  • Visakhapatnam, Madhya Pradesh.

Other popular Pharmaceutical Companies operated by the Government of India in India;

These all companies are operated by the Government of India

  • Indian Drugs and Pharmaceutical Companies
  • Hindustan Antibiotics Ltd.
  • Rajasthan Drugs & Pharmaceutical Ltd.
  • Karnataka Antibiotics & Pharmaceutical Ltd.
  • Bengal Chemicals & Pharmaceutical Ltd.
  • Goa Antibiotics & Pharmaceutical Ltd.
Sharing Is Caring:

Leave a Comment